The papers featured in this months, (October 2021) issue of, 'The Oxford Journal of Infectious Diseases'

This month the famous publication is having a celebration of vaccines (wonder why that is?) and has released a number of papers on various vaccines and the challenges they still face?

1) Triumphs of immunisation

2) The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease

3) Hepatitis B Vaccines

4) Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster

5) Smallpox

6) Influenza Vaccines: Successes and Continuing Challenges

7) T he World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade

Sorry, i accidentally forgot to attach these to that last drop

1) Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination

2) Rubella Eradication: Not Yet Accomplished, but Entirely Feasible

Vigiaccess (not, 'Vagina access', like i first thought and was disappointed wasn't porn! 😋)

1) Vigiaccess: : Promoting public access to VigiBase

2) Upsalla monitoring centre: Vigiaccess manual

3) Pharmacovigilance and expedited drug  approvals

4) Serious adverse events reported from the COVID-19 vaccines: A denoscriptive study based on WHO database

5) WHO Database of adverse events

6) Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview

7) WEB-RADR App Overview (mobile reporting platform)

8) SCOPE ADR reporting

9) Pharmacovigilance Programme of India

10) Pharmacovigilance in Pediatric Population

11) Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports

12) Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety

13) Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety

14) Frequency and Severity of Adverse Drug Reactions to Medications Prescribed for Alzheimer’s Disease in aBrazilian City: Cross-Sectional Study

15) WHO Covid vaccine safety manual